Only the significantly increased levels of IL-1ß had the potential to serve as an appropriate biomarker for recurrent tonsillitis (153.7 ± 48.5 pg/ml vs 23.3 ± 6.6 pg/ml, p = 0.021) (Fig. 1 L). This evidence concerns the gene IL1B and medical procedure.